These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11296046)

  • 41. Emotional symptoms are secondary to the voice disorder in patients with spasmodic dysphonia.
    Liu CY; Yu JM; Wang NM; Chen RS; Chang HC; Li HY; Tsai CH; Yang YY; Lu CS
    Gen Hosp Psychiatry; 1998 Jul; 20(4):255-9. PubMed ID: 9719906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin injections for the treatment of spasmodic dysphonia.
    Watts CC; Whurr R; Nye C
    Cochrane Database Syst Rev; 2004; 2004(3):CD004327. PubMed ID: 15266530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
    Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin type B for treatment of spasmodic dysphonia: a case report.
    Sataloff RT; Heman-Ackah YD; Simpson LL; Park JB; Zwislewski A; Sokolow C; Mandel S
    J Voice; 2002 Sep; 16(3):422-4. PubMed ID: 12395995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A.
    Guntinas-Lichius O
    Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439
    [No Abstract]   [Full Text] [Related]  

  • 47. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series.
    Blitzer A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():28-30. PubMed ID: 20590805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
    Brin MF; Blitzer A; Stewart C
    Adv Neurol; 1998; 78():237-52. PubMed ID: 9750921
    [No Abstract]   [Full Text] [Related]  

  • 50. Tardive dystonia, a case report.
    Veras AB; Rozenthal M; Nardi AE
    Braz J Psychiatry; 2006 Jun; 28(2):160-1. PubMed ID: 16810405
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of botulinum toxin in Meige's disease.
    Maurri S; Brogelli S; Alfieri G; Barontini F
    Riv Neurol; 1988; 58(6):245-8. PubMed ID: 3247565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.
    Truong DD; Bhidayasiri R
    Eur J Neurol; 2006 Feb; 13 Suppl 1():36-41. PubMed ID: 16417596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin.
    Courey MS; Garrett CG; Billante CR; Stone RE; Portell MD; Smith TL; Netterville JL
    Ann Otol Rhinol Laryngol; 2000 Sep; 109(9):819-22. PubMed ID: 11007083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections.
    Aronson AE; McCaffrey TV; Litchy WJ; Lipton RJ
    Laryngoscope; 1993 Jun; 103(6):683-92. PubMed ID: 8502104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adduction spastic dysphonia: clinical and treatment].
    García Ruiz PJ; Sánchez del Río M; Cenjor Español C; Sanabria Brassart J; Sánchez Bernardos V; Astarloa Gómez R; García de Yébenes J
    Rev Clin Esp; 1998 Mar; 198(3):156-8. PubMed ID: 9586438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
    Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
    Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum toxin treatment in clinical neurology.
    Van den Bergh P
    Acta Neurol Belg; 1995; 95(2):70-9. PubMed ID: 7618431
    [No Abstract]   [Full Text] [Related]  

  • 59. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).
    Blitzer A; Brin MF; Fahn S; Lovelace RE
    Laryngoscope; 1988 Feb; 98(2):193-7. PubMed ID: 3339931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial.
    van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA
    BMC Neurol; 2013 Jul; 13():85. PubMed ID: 23855591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.